Table 2.
Cancer | Source | Biomarker | Number | Reg. NO |
---|---|---|---|---|
Gastric | Plasma | Exosome | 80 | NCT01779583 |
Cancer | Serum | MiR-15b-3p | Wei et al., 2020155 | |
Hepatocellular | Serum | miRNA-21 | Lee et al., 2019156 | |
Carcinoma | Urine | Phospholipid | ChiCTR2200065653 | |
Colorectal | Serum | Has-circ-0004771 | Pan et al., 2019157 | |
Cancer | Blood | EXOSCOL01 | 80 | NCT04394572 |
Non-small cell | Plasma | CD63; EGFR; | Fan et al., 2020158 | |
Lung Cancer | Blood | CD8+; EGFR | ChiCTR2200061697 | |
Plasma | 150 | NCT05587114 | ||
Serum | LncRNA | 1000 | NCT03830619 | |
Small Cell | Plasma | Non-coding RNA | ChiCTR2200064246 | |
Lung Cancer | ||||
Prostatic | Urine | MiR-196a | Rodríguez et al., 2017159 | |
Cancer | ||||
Cholangiocarcinoma | Plasma | NcRNA | 80 | NCT03102268 |
Ovarian Cancer | Plasma | CA125; CD24 | 90 | Im et al., 2014160 |
Breast Cancer | Blood | CA153 | 90 | Wang et al., 2017161 |
Plasma | 100 | NCT01344109 | ||
Osteosarcoma | Blood | RNA | 50 | NCT03108677 |
Clear cell | Urine | CD9+ | 74 | NCT04053855 |
Renal Cancer | ||||
Thyroid | Urine | Thyroglobulin | 30 | NCT05463107 |
Cancer | Urine | Galectin −3 | NCT03488134 | |
Saliva | HPV | NCT02147418 | ||
Oropharyngeal Cancer |